Nutex Health is trading 10.31% down at $179.51, with no confirmed company-specific explanation for the decline. - On November 2, 2026, no clear company-specific announcement explaining the decline surfaced in available coverage. - Third-quarter results are scheduled for November 5, after the market close. - The broader market is higher, so available context does not point to a market-wide decline; the immediate catalyst remains unclear.